Therapy Analysis & Statistics, January 2015 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

271-300 of about 2 200 reports

Purchase Reports From Reputable Market Research Publishers

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Pacific Therapeutics Ltd. (PT) - Financial and Strategic SWOT Analysis Review

Pacific Therapeutics Ltd. (PT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Pacific Therapeutics Ltd. (Pacific) is a pharmaceutical company. The company identifies, develops and sells drug candidates to treat diseases of the liver and lungs. Its product PTL-202 is a clinical ...

  • Industries : Therapy
  • Countries : Canada
Pernix Therapeutics Holdings, Inc. (Symbol:PTX) SWOT Analysis, Strategy, Revenues and Profits

Pernix Therapeutics Holdings, Inc. (Symbol:PTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Pluristem Therapeutics Inc. (Symbol:PSTI) SWOT Analysis, Strategy, Revenues and Profits

Pluristem Therapeutics Inc. (Symbol:PSTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Israel, South Africa
Protalix BioTherapeutics, Inc. (Symbol:PLX) SWOT Analysis, Strategy, Revenues and Profits

Protalix BioTherapeutics, Inc. (Symbol:PLX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Quest PharmaTech Inc. (Symbol:QPT) SWOT Analysis, Strategy, Revenues and Profits

Quest PharmaTech Inc. (Symbol:QPT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Repros Therapeutics Inc. (Symbol:RPRX) SWOT Analysis, Strategy, Revenues and Profits

Repros Therapeutics Inc. (Symbol:RPRX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Rossmax International Ltd. (Symbol:4121) SWOT Analysis, Strategy, Revenues and Profits

Rossmax International Ltd. (Symbol:4121) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Taiwan
Transition Therapeutics Inc. (Symbol:TTH) SWOT Analysis, Strategy, Revenues and Profits

Transition Therapeutics Inc. (Symbol:TTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Canada
Zynex Medical, Inc. (Symbol:ZYXI) SWOT Analysis, Strategy, Revenues and Profits

Zynex Medical, Inc. (Symbol:ZYXI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Cyberonics, Inc. (Symbol:CYBX) SWOT Analysis, Strategy, Revenues and Profits

Cyberonics, Inc. (Symbol:CYBX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Sorrento Therapeutics, Inc. (Symbol:SRNE) SWOT Analysis, Strategy, Revenues and Profits

Sorrento Therapeutics, Inc. (Symbol:SRNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
The Ensign Group, Inc. (Symbol:ENSG) SWOT Analysis, Strategy, Revenues and Profits

The Ensign Group, Inc. (Symbol:ENSG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Silence Therapeutics plc (Symbol:SLN) SWOT Analysis, Strategy, Revenues and Profits

Silence Therapeutics plc (Symbol:SLN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Galectin Therapeutics, Inc. (Galectin Therapeutics) is a biotechnology company. The company discovers, develops and commercializes therapies for fibrotic disease and cancer. Its products include ...

  • Industries : Therapy
D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review

D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary D. Western Therapeutics Institute, Inc. (DWTI) is a pharmaceutical company. The company discovers and develops new drugs. Its products include K-134, K-115, HMN-214, and HMN-1129. DWTI's K-134 ...

  • Industries : Therapy
  • Countries : Japan
Pivotal Therapeutics Inc. (PVO) - Financial and Strategic SWOT Analysis Review

Pivotal Therapeutics Inc. (PVO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Pivotal Therapeutics Inc. (Pivotal Therapeutics) is a pharmaceutical company. The company produces and markets therapeutic products for cardiovascular disease and overall health. Its products include ...

  • Industries : Therapy
  • Countries : United States, Canada
Orpea SA (ORP) - Financial and Strategic SWOT Analysis Review

Orpea SA (ORP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Orpea SA (Orpea) is a healthcare service provider. The company offers clinical care, rehabilitation and psychiatric services. Its clinical care services include sub acute care and rehabilitation, ...

  • Industries : Therapy
  • Countries : Switzerland, Spain, Italy, France, Belgium
Regulus Therapeutics Inc. (RGLS) - Financial and Strategic SWOT Analysis Review

Regulus Therapeutics Inc. (RGLS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Regulus Therapeutics Inc. (Regulus Therapeutics) is a biopharmaceutical company. The company discovers, develops and commercializes microRNA based therapeutics. It develops single stranded oligonucleotides, ...

  • Industries : Therapy
  • Countries : United States
Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review

Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Esperion Therapeutics, Inc. (Esperion) is a biotechnology company. The company develops and commercializes oral, small molecule therapies for the treatment of patients with low-density lipoprotein ...

  • Industries : Therapy
  • Countries : United States
Onconova Therapeutics, Inc. (ONTX) - Financial and Strategic SWOT Analysis Review

Onconova Therapeutics, Inc. (ONTX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Onconova Therapeutics, Inc. (Onconova) is a biopharmaceutical company. The company discovers and develops novel small molecule drug candidates to treat cancer. It develops targeted anti-cance ...

  • Industries : Therapy
  • Countries : United States
Stemline Therapeutics, Inc. (STML) - Financial and Strategic SWOT Analysis Review

Stemline Therapeutics, Inc. (STML) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Stemline Therapeutics, Inc. (Stemline) is a clinical stage biopharmaceutical company. The company develops oncology compounds, which targets both cancer stem cells (CSC's) and the tumor bulk. Its ...

  • Industries : Therapy
  • Countries : United States
Capstone Therapeutics Corp. (CAPS) - Financial and Strategic SWOT Analysis Review

Capstone Therapeutics Corp. (CAPS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Capstone Therapeutics Corp. (Capstone) is a biotechnology company. The company develops novel peptides and other molecules to support patients with under-served medical conditions. It develops ...

  • Industries : Therapy
  • Countries : United States
Sevion Therapeutics, Inc. (SVON) - Financial and Strategic SWOT Analysis Review

Sevion Therapeutics, Inc. (SVON) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Sevion Therapeutics, Inc.(Sevion) is a cancer therapeutic company. The company provides eukaryotic translation initiation Factor 5A (eIF5A) technology to regulate cell death and survival. It offers ...

  • Industries : Therapy
  • Countries : United States
Tesaro, Inc. (TSRO) - Financial and Strategic SWOT Analysis Review

Tesaro, Inc. (TSRO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Tesaro, Inc. (Tesaro) is an oncology-focused biopharmaceutical company. It focuses on acquiring, in-licensing, developing and commercializing oncology therapeutics and supportive care products. ...

  • Industries : Therapy
  • Countries : United States
Aratana Therapeutics Inc. (PETX) - Financial and Strategic SWOT Analysis Review

Aratana Therapeutics Inc. (PETX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Aratana Therapeutics, Inc. (Aratana) is a pet therapeutics company. It undertakes the acquisition, development and commercialization of biopharmaceutical products to address the unmet medical needs ...

  • Industries : Therapy
  • Countries : United States
Allon Therapeutics Inc. (Symbol:NPC) SWOT Analysis, Strategy, Revenues and Profits

Allon Therapeutics Inc. (Symbol:NPC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Canada, New Zealand
Capstone Therapeutics Corp. (Symbol:CAPS) SWOT Analysis, Strategy, Revenues and Profits

Capstone Therapeutics Corp. (Symbol:CAPS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Huiheng Medical, Inc. (Symbol:HHGM) SWOT Analysis, Strategy, Revenues and Profits

Huiheng Medical, Inc. (Symbol:HHGM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : China
Integrative Therapeutics, Inc. SWOT Analysis, Strategy, Revenues and Profits

Integrative Therapeutics, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
About 300 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Industry - Company Report, 2015

  • January 2015
    2 pages
  • Therapy  

    Credit And Loan  

  • United States  

View report >

Therapy Markets In The Us

September 2014

52 Companies

Read our Company Profiles

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

Bristol-Myers Squibb Co.

United States

GlaxoSmithKline PLC

United Kingdom

Baxter Healthcare Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.